Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections

PURPOSE: High-dose methotrexate (HD-MTX) has been used to treat children with central nervous system tumors. Accumulation of MTX within pleural, peritoneal, or cardiac effusions has led to delayed excretion and increased risk of systemic toxicity. This retrospective study analyzed the association of...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Chemother Pharmacol
Main Authors: Wright, Karen D., Panetta, John C., Onar-Thomas, Arzu, Reddick, Wilburn E., Patay, Zoltan, Qaddoumi, Ibrahim, Broniscer, Alberto, Robinson, Giles, Boop, Frederick A., Klimo, Paul, Ward, Deborah, Gajjar, Amar, Stewart, Clinton F.
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282603/
https://ncbi.nlm.nih.gov/pubmed/25342291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-014-2614-6
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares